These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 24486333)

  • 1. Cell-line-specific high background in the Proteasome-Glo assay of proteasome trypsin-like activity.
    Wilkins OM; Downey SL; Weyburne ES; Williams DA; Mirabella AC; Overkleeft HS; Kisselev AF
    Anal Biochem; 2014 Apr; 451():1-3. PubMed ID: 24486333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The capture proteasome assay: A method to measure proteasome activity in vitro.
    Vigneron N; Abi Habib J; Van den Eynde BJ
    Anal Biochem; 2015 Aug; 482():7-15. PubMed ID: 25912419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-based bioluminescent assays for all three proteasome activities in a homogeneous format.
    Moravec RA; O'Brien MA; Daily WJ; Scurria MA; Bernad L; Riss TL
    Anal Biochem; 2009 Apr; 387(2):294-302. PubMed ID: 19454251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Importance of the different proteolytic sites of the proteasome and the efficacy of inhibitors varies with the protein substrate.
    Kisselev AF; Callard A; Goldberg AL
    J Biol Chem; 2006 Mar; 281(13):8582-90. PubMed ID: 16455650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous fluorescent monitoring of proteasomal subunit catalysis.
    Wakata A; Lee HM; Rommel P; Toutchkine A; Schmidt M; Lawrence DS
    J Am Chem Soc; 2010 Feb; 132(5):1578-82. PubMed ID: 20078037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring activity and inhibition of 26S proteasomes with fluorogenic peptide substrates.
    Kisselev AF; Goldberg AL
    Methods Enzymol; 2005; 398():364-78. PubMed ID: 16275343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fetal calf sera can distort cell-based luminescent proteasome assays through heat-resistant chymotrypsin-like activity.
    Dettmer S; Theile D; Seckinger A; Burhenne J; Weiss J
    Anal Biochem; 2015 Feb; 471():23-5. PubMed ID: 25447494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apigenin, chrysin, and luteolin selectively inhibit chymotrypsin-like and trypsin-like proteasome catalytic activities in tumor cells.
    Wu YX; Fang X
    Planta Med; 2010 Feb; 76(2):128-32. PubMed ID: 19653143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homogeneous, bioluminescent proteasome assays.
    O'Brien MA; Moravec RA; Riss TL; Bulleit RF
    Methods Mol Biol; 2015; 1219():95-114. PubMed ID: 25308265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydrogen Peroxide-Induced Oxidative Stress Activates Proteasomal Trypsin-Like Activity in Human U373 Glioma Cells.
    Nakayama N; Yamaguchi S; Sasaki Y; Chikuma T
    J Mol Neurosci; 2016 Feb; 58(2):297-305. PubMed ID: 26563451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homogeneous, bioluminescent proteasome assays.
    O'Brien MA; Moravec RA; Riss TL; Bulleit RF
    Methods Mol Biol; 2008; 414():163-81. PubMed ID: 18175819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human 20S proteasome activity towards fluorogenic peptides of various chain lengths.
    Rut W; Drag M
    Biol Chem; 2016 Sep; 397(9):921-6. PubMed ID: 27176742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pitfalls in invertebrate proteasome assays.
    Götze S; Bose A; Abele D; Sokolova IM; Saborowski R
    J Exp Biol; 2013 Apr; 216(Pt 8):1351-4. PubMed ID: 23264486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluorescent Probes with Unnatural Amino Acids to Monitor Proteasome Activity in Real-Time.
    Zerfas BL; Coleman RA; Salazar-Chaparro AF; Macatangay NJ; Trader DJ
    ACS Chem Biol; 2020 Sep; 15(9):2588-2596. PubMed ID: 32786259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective inhibitor of proteasome's caspase-like sites sensitizes cells to specific inhibition of chymotrypsin-like sites.
    Britton M; Lucas MM; Downey SL; Screen M; Pletnev AA; Verdoes M; Tokhunts RA; Amir O; Goddard AL; Pelphrey PM; Wright DL; Overkleeft HS; Kisselev AF
    Chem Biol; 2009 Dec; 16(12):1278-89. PubMed ID: 20064438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific cell-permeable inhibitor of proteasome trypsin-like sites selectively sensitizes myeloma cells to bortezomib and carfilzomib.
    Mirabella AC; Pletnev AA; Downey SL; Florea BI; Shabaneh TB; Britton M; Verdoes M; Filippov DV; Overkleeft HS; Kisselev AF
    Chem Biol; 2011 May; 18(5):608-18. PubMed ID: 21609842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteasome inhibition correlates with intracellular bortezomib concentrations but not with antiproliferative effects after bolus treatment in myeloma cell lines.
    Dettmer S; Theile D; Schäfer J; Seckinger A; Burhenne J; Weiss J
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Oct; 389(10):1091-101. PubMed ID: 27422413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The caspase-like sites of proteasomes, their substrate specificity, new inhibitors and substrates, and allosteric interactions with the trypsin-like sites.
    Kisselev AF; Garcia-Calvo M; Overkleeft HS; Peterson E; Pennington MW; Ploegh HL; Thornberry NA; Goldberg AL
    J Biol Chem; 2003 Sep; 278(38):35869-77. PubMed ID: 12815064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Peptidomimetic Fluorescent Probe to Detect the Trypsin β2 Subunit of the Human 20S Proteasome.
    Wysocka M; Romanowska A; Gruba N; Michalska M; Giełdoń A; Lesner A
    Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32244300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific inhibition of the chymotrypsin-like activity of the proteasome induces a bipolar morphology in neuroblastoma cells.
    Fenteany G; Schreiber SL
    Chem Biol; 1996 Nov; 3(11):905-12. PubMed ID: 8939705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.